One cancer patient says he probably wouldn’t be here today if it weren’t for getting the test after he was diagnosed with ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

With delays in biomarker testing and treatment for metastatic castration-resistant prostate cancer, continued education is ...

The American Cancer Society Cancer Action Network (ACS CAN) gathered at the state capitol to advocate for LB253, a bill proposed by Senator Elio ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

Phase I clinical trials are the first step in testing a new treatment or combination of treatments. These trials often ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...

Portable point-of-care blood tests, done by EMS before hospital arrival, need validation but could guide treatment and ...

PITTSBURGH (KDKA) — A breakthrough in the fight against Alzheimer's was made by researchers at the University of Pittsburgh, where a test was created to detect the disease in the brain earlier.